MB

Marianne Bjordal

Partner at 3B Future Health Ventures

Greater Nice Metropolitan Area

Overview

Work Experience

HG

Helsinn Group -3B Future Health Ventures

  • Partner

    2022 - Current

  • Senior Associate

    2019 - 2022

  • Investment Analyst

    2018 - 2019

SB

Sibylla Biotech

  • Board Member

    2022

EL

Epsilogen Ltd

  • Board member

    2022

KB

Kither Biotech

  • Board Observer

    2022

GenEp Inc

  • Board member

    2021

NL

NeoPhore Ltd

  • Board member

    2021

GT

Gain Therapeutics

  • Board Member

    2020 - 2021

V

Virbac

  • Project Monitor

    2018 - 2018

C

CNRS

  • Researcher

    2012 - 2017

    Neurobiology, genetics, growth, metabolism and development

  • PhD fellow

    2005 - 2011

    Marie Curie Early Stage Researcher

Nf

Norges forskningsråd

  • PhD fellow

    2006 - 2011

Education

Investments

Sibylla Biotech

Series A

Total Funding: $23M

Epsilogen

Series B

Total Funding: $47M

GenEp

Seed

Total Funding: $1M

Relevant Websites